Daniel Lord, MD
Gastroenterology · Duluth, GANPI 1245224344
Payments from drug & device makers
Across 241 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$530
- Braintree Laboratories, Inc.$485
- Intercept Pharmaceuticals, Inc.$216
- Ferring Pharmaceuticals Inc.$172
- Takeda Pharmaceuticals U.S.A., Inc.$166
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,73192%
- Education$321%
- Gifts$3118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 98 | $1,203 |
| Pfizer | 29 | $530 |
| Braintree Laboratories, Inc. | 15 | $485 |
| Intercept Pharmaceuticals, Inc. | 11 | $216 |
| Ferring Pharmaceuticals Inc. | 10 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $166 |
| Redhill Biopharma Inc. | 8 | $126 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $101 |
| Johnson & Johnson | 4 | $95 |
| Bristol Myers Squibb | 5 | $76 |
| Daiichi Sankyo Inc. | 4 | $70 |
| QOL Medical, LLC | 2 | $64 |
| Merck | 4 | $62 |
| Medtronic | 3 | $60 |
| Madrigal Pharmaceuticals | 3 | $53 |
| Amgen | 3 | $53 |
| Ironwood Pharmaceuticals, Inc | 3 | $51 |
| Ardelyx, Inc. | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $44 |
| Evoke Pharma, Inc. | 2 | $30 |
| Sanofi | 1 | $29 |
| Gilead | 2 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Celltrion USA Inc. | 1 | $24 |
| Intuitive Surgical | 1 | $22 |
| Olympus America Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Mylan Institutional Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Micro-tech Endoscopy USA, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$4,075 in reported general payments places this provider in the 50th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 27 | $367,601 |
| LinzessLinaclotide | 55 | $48,741 |
| ViberziEluxadoline | 21 | $42,032 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 472 | $31,706 |
| Mesalamine | 34 | $11,087 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 43 | $7,403 |
| Colesevelam Hcl | 22 | $6,248 |
| Colestipol Hcl | 49 | $5,647 |
| Pantoprazole Sodium | 464 | $5,172 |
| CholestyramineCholestyramine (With Sugar) | 85 | $4,458 |
| Budesonide EcBudesonide | 14 | $3,738 |
| Ursodiol | 35 | $3,262 |
| Mesalamine ErMesalamine | 21 | $2,894 |
| Budesonide DrBudesonide | 27 | $2,421 |
| Balsalazide Disodium | 17 | $2,382 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Viberzi | $1,203 | $90,77376 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $172 | $7,40343 claims |
| Braintree Laboratories, Inc.Sutab | $485 | $2,10713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Duluth
- Douglas WolfAtlanta$6.4M
- Aasim SheikhMarietta$6M
- Shahriar SedghiMacon$5.4M
- Jeffrey WilliamsAthens$2.5M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
- Bruce SalzbergSuwanee$1.4M
- Heba IskandarAtlanta$978K
- David RausherDecatur$907K
- Florence Hosseini AsliniaHiram$885K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.